Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 2

Advancing QSP: From Virtual Patient To Digital Twin

Panel Discussion

Tuesday, November 12, 2024
3:00 PM – 3:30 PM MST
Location: Kaibab & Lantana

    Panelist(s)

  • JG

    Jingqi Gong, PhD (she/her/hers)

    Associate Director, Quantitative Systems Pharmacology
    GlaxoSmithKline, United States

    Disclosure(s): No financial relationships to disclose

  • Oleg Demin Jr (he/him/his)

    Scientific Director, Oncology & Immuno-Oncology Quantitative Systems Pharmacology
    InSysBio CY, Cyprus

    Disclosure(s): No financial relationships to disclose

  • RA

    Richard Allen, PhD

    Research Fellow and Quantitative Systems Pharmacology Lead
    Pfizer, United States

    Disclosure(s): Pfizer Inc: Employment (Ongoing)

  • Susana Zaph, PhD (she/her/hers)

    Senior Director & Head of Translational Disease Modeling - US
    Sanofi
    Bridgewater, New York, United States

    Disclosure(s): Sanofi: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Disclosure(s):
Jingqi Gong, PhD: No financial relationships to disclose
Oleg Demin Jr: No financial relationships to disclose
Richard Allen, PhD: Pfizer Inc: Employment (Ongoing)
Susana Zaph, PhD: Sanofi: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)